Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fred E. Cohen Insider Profile
4 Followers
Fred E. Cohen, Director at Genomic Health, holds 4.52M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 69.34K shares in Urogen Pharma (Ticker: URGN), holds 132.59K shares in CareDx (Ticker: CDNA).
Profitable Transactions
7 out of 15 Profitable Transactions
Average Return
-6.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fred E. Cohen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Fred E. Cohen
Fred E. Cohen's Trading History
Genomic Health
Nov 14, 2019
―
Uninformative Sell
―
$0.00
Intellia Therapeutics
Jun 16, 2023
Director
Uninformative Buy
―
$866.02K
Urogen Pharma
Jul 28, 2023
Director
Uninformative Buy
661.49K
$981.15K
Progyny
May 26, 2023
Director
Uninformative Buy
―
$529.20K
Kyverna Therapeutics, Inc.
Feb 14, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$69.99M
BioCryst
Sep 20, 2017
Director
Informative Sell
294.04K
$435.42K
CareDx
Jun 21, 2023
Director
Uninformative Buy
―
$1.00M
Five Prime Therapeutics
Jan 13, 2016
―
Informative Buy
245.29K
$942.67K
Tandem Diabetes Care
―
Director
―
$0.00
Veracyte
Oct 20, 2020
Director
Informative Buy
76.00K
$193.10K
Sorrento Tech Inc
―
―
―
$0.00
IQVIA Holdings
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Fred E. Cohen's performance on stock
You May Also Like
Fred E. Cohen insider profile FAQ
What is the percentage of profitable transactions made by Fred E. Cohen?
The percentage of profitable transactions made by Fred E. Cohen is 47%.
What is the average return per transaction made by Fred E. Cohen?
The average return per transaction made by Fred E. Cohen is -6.00%.
What stocks does Fred E. Cohen hold?
Fred E. Cohen holds: GHDX, NTLA, URGN, PGNY, KYTX, BCRX, CDNA, FPRX, TNDM, VCYT, ROKA, IQV stocks.
What was Fred E. Cohen’s latest transaction?
Fred E. Cohen latest transaction was an Uninformative Buy of ―.
What was Fred E. Cohen's most profitable transaction?
Fred E. Cohen’s most profitable transaction was an Informative Buy of CDNA stock on September 22, 2020. The return on the trade was 97.60%.
What is Fred E. Cohen's role in Genomic Health?
Fred E. Cohen's role in Genomic Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.